Founded in 2006, ChemExpress (Stock Code: 688131.SH), the parent company of MedChemExpress (MCE), is one of the leading Contract Development and Manufacturing Organizations (CDMOs). We focus on providing small molecules, ADC payload-linker, and new modalities to our clients. Our comprehensive CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. We are a one-stop service platform to support our client’s projects from early drug discovery, process development to commercialization.